<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The aim of this study was to clarify the clinical outcome and significance of mediastinal lymph node dissection (LND) during pulmonary resection of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> from colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective chart review was performed </plain></SENT>
<SENT sid="2" pm="."><plain>Between April 1985 and December 2009, 518 patients underwent 720 pulmonary metastasectomies for metastatic colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Relevant factors were analyzed with the Ï‡2 or Fisher exact test and the Mann-Whitney test </plain></SENT>
<SENT sid="4" pm="."><plain>Survival and lymph node (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) recurrence-free period after pulmonary metastasectomy were analyzed with Kaplan-Meier and Cox proportional hazards methods </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The overall 5-year and 10-year survival rate after pulmonary metastasectomy were 47.1% and 27.7%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The only significant prognostic factor for survival after pulmonary metastasectomy was mediastinal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p=0.047 in univariate and 0.0028 in multivariate analysis); 199 patients did not undergo LND, 279 patients underwent LND that were negative, and 40 patients underwent LND that contained 1 or more positive mediastinal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The sensitivity of <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomographic scan for detecting mediastinal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> was only 35% </plain></SENT>
<SENT sid="8" pm="."><plain>Although long-term survivors were present, systematic LND was not a significant factor for prolonged survival (p=0.26) in the positive LND group </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Mediastinal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> are a significant negative prognostic factor for survival after pulmonary metastasectomy for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Computed tomography and <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography based imaging, as well as preoperative carcinoembryonic antigen levels have poor sensitivity for detecting malignant mediastinal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> in this setting </plain></SENT>
<SENT sid="11" pm="."><plain>Systematic mediastinal LND should be performed for prognostic purposes during pulmonary metastasectomy for colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
</text></document>